SRT1720, a small molecule SIRT1 activator, can promote glucose homeostasis (whole-body) and insulin sensitivity in adipose tissue, skeletal muscle and liver as observed in multiple in vivo models of T2DM [191]. This evidence concerns the gene SIRT1 and type 2 diabetes mellitus.